The number of ISA millionaires is growing all the time and guess what? They're really into blue-chip dividend shares listed ...
Cambridge, USA-based Vesalius Therapeutics has entered into a multi-target strategic alliance with the UK’s GSK to discover ...
DelveInsight's Dermatological Drugs Market Insights report provides the current and forecast market analysis, individual ...
Consider taking independent financial advice. Mark Hartley has positions in AstraZeneca Plc and GSK. The Motley Fool UK has recommended AstraZeneca Plc, GSK, Rolls-Royce Plc, Tesla, and Workday. Views ...